These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26588902)

  • 1. Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa.
    Kharsany AB; Cawood C; Khanyile D; Grobler A; Mckinnon LR; Samsunder N; Frohlich JA; Abdool Karim Q; Puren A; Welte A; George G; Govender K; Toledo C; Chipeta Z; Zembe L; Glenshaw MT; Madurai L; Deyde VM; Bere A
    BMC Public Health; 2015 Nov; 15():1149. PubMed ID: 26588902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress of UNAIDS 90-90-90 targets in a district in KwaZulu-Natal, South Africa, with high HIV burden, in the HIPSS study: a household-based complex multilevel community survey.
    Grobler A; Cawood C; Khanyile D; Puren A; Kharsany ABM
    Lancet HIV; 2017 Nov; 4(11):e505-e513. PubMed ID: 28779855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based HIV prevalence in KwaZulu-Natal, South Africa: results of a cross-sectional household survey.
    Kharsany ABM; Cawood C; Khanyile D; Lewis L; Grobler A; Puren A; Govender K; George G; Beckett S; Samsunder N; Madurai S; Toledo C; Chipeta Z; Glenshaw M; Hersey S; Abdool Karim Q
    Lancet HIV; 2018 Aug; 5(8):e427-e437. PubMed ID: 30021700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HIV testing and treatment services on risky sexual behaviour in the uMgungundlovu District, KwaZulu-Natal, South Africa: a cross-sectional study.
    George G; Beckett S; Cawood C; Khanyile D; Govender K; Kharsany ABM
    AIDS Res Ther; 2019 Aug; 16(1):20. PubMed ID: 31434574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
    Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; Bärnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F;
    Trials; 2013 Jul; 14():230. PubMed ID: 23880306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological non-suppression and associated factors among adult patients receiving antiretroviral therapy at selected health facilities in uMgungundlovu district of KwaZulu Natal, South Africa: a cross-sectional study.
    Zondi S; Cele L; Mathibe M; Mogale M
    Pan Afr Med J; 2024; 47():96. PubMed ID: 38799193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa.
    Haber N; Tanser F; Bor J; Naidu K; Mutevedzi T; Herbst K; Porter K; Pillay D; Bärnighausen T
    Lancet HIV; 2017 May; 4(5):e223-e230. PubMed ID: 28153470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).
    Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Pillay D; Dabis F; Orne-Gliemann J;
    J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25128. PubMed ID: 30027600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating DREAMS HIV prevention interventions targeting adolescent girls and young women in high HIV prevalence districts in South Africa: protocol for a cross-sectional study.
    George G; Cawood C; Puren A; Khanyile D; Gerritsen A; Govender K; Beckett S; Glenshaw M; Diallo K; Ayalew K; Gibbs A; Reddy T; Madurai L; Kufa-Chakezha T; Kharsany ABM
    BMC Womens Health; 2020 Jan; 20(1):7. PubMed ID: 31948429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
    Huerga H; Van Cutsem G; Ben Farhat J; Puren A; Bouhenia M; Wiesner L; Dlamini L; Maman D; Ellman T; Etard JF
    BMC Public Health; 2018 Mar; 18(1):303. PubMed ID: 29499668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa.
    Kharsany ABM; Cawood C; Lewis L; Yende-Zuma N; Khanyile D; Puren A; Madurai S; Baxter C; George G; Govender K; Beckett S; Samsunder N; Toledo C; Ayalew KA; Diallo K; Glenshaw M; Herman-Roloff A; Wilkinson E; de Oliveira T; Abdool Karim SS; Abdool Karim Q
    JAMA Netw Open; 2019 Nov; 2(11):e1914378. PubMed ID: 31675082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study.
    de Oliveira T; Kharsany AB; Gräf T; Cawood C; Khanyile D; Grobler A; Puren A; Madurai S; Baxter C; Karim QA; Karim SS
    Lancet HIV; 2017 Jan; 4(1):e41-e50. PubMed ID: 27914874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.
    Hunt GM; Dokubo EK; Takuva S; de Oliveira T; Ledwaba J; Dube N; Moodley P; Sabatier J; Deyde V; Morris L; Raizes E
    J Antimicrob Chemother; 2017 Nov; 72(11):3141-3148. PubMed ID: 28981637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Potential Factors Associated with High HIV viral load in KwaZulu-Natal, South Africa using Multiple Correspondence Analysis and Random Forest Analysis.
    Soogun AO; Kharsany ABM; Zewotir T; North D; Ogunsakin RE
    BMC Med Res Methodol; 2022 Jun; 22(1):174. PubMed ID: 35715730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).
    Parikh UM; Kiepiela P; Ganesh S; Gomez K; Horn S; Eskay K; Kelly C; Mensch B; Gorbach P; Soto-Torres L; Ramjee G; Mellors JW;
    PLoS One; 2013; 8(4):e59787. PubMed ID: 23585827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
    Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
    PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa.
    Busang J; Zuma T; Herbst C; Okesola N; Chimbindi N; Dreyer J; Mtshali N; Smit T; Ngubane S; Hlongwane S; Gumede D; Jalazi A; Mdluli S; Bird K; Msane S; Danisa P; Hanekom W; Lebina L; Behuhuma N; Hendrickson C; Miot J; Seeley J; Harling G; Jarolimova J; Sherr L; Copas A; Baisley K; Shahmanesh M
    BMC Public Health; 2023 Aug; 23(1):1553. PubMed ID: 37582746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.